NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

Susan M. Swetter; Douglas Johnson; Mark R. Albertini; Christopher A. Barker; Sarah Bateni; Joel Baumgartner; Shailender Bhatia; Christopher Bichakjian; Genevieve Boland; Sunandana Chandra; Bartosz Chmielowski; Dominick DiMaio; Roxana Dronca; Ryan C. Fields; Martin D. Fleming; Anjela Galan; Samantha Guild; John Hyngstrom; Giorgos Karakousis; Kari Kendra; Maija Kiuru; Julie R. Lange; Ryan Lanning; Theodore Logan; Daniel Olson; Anthony J. Olszanski; Patrick A. Ott; Merrick I. Ross; Luke Rothermel; April K. Salama; Rohit Sharma; Joseph Skitzki; Emily Smith; Katy Tsai; Evan Wuthrick; Yan Xing; Nicole McMillian; Sara Espinosa

doi:10.6004/jnccn.2024.0036

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

Susan M. Swetter, Douglas Johnson, Mark R. Albertini, Christopher A. Barker, Sarah Bateni, Joel Baumgartner, Shailender Bhatia, Christopher Bichakjian, Genevieve Boland, Sunandana Chandra, Bartosz Chmielowski, Dominick DiMaio, Roxana Dronca, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Samantha Guild, John Hyngstrom, Giorgos Karakousis, Kari KendraMaija Kiuru, Julie R. Lange, Ryan Lanning, Theodore Logan, Daniel Olson, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, Luke Rothermel, April K. Salama, Rohit Sharma, Joseph Skitzki, Emily Smith, Katy Tsai, Evan Wuthrick, Yan Xing, Nicole McMillian, Sara Espinosa

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

Original language	English
Pages (from-to)	290-298
Number of pages	9
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	22
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2024.0036
State	Published - Jul 1 2024

Keywords

Humans
Medical Oncology/standards
Melanoma/therapy
Neoplasm Staging
Skin Neoplasms/therapy

Access to Document

10.6004/jnccn.2024.0036

Cite this

Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chmielowski, B., DiMaio, D., Dronca, R., Fields, R. C., Fleming, M. D., Galan, A., Guild, S., Hyngstrom, J., Karakousis, G., ... Espinosa, S. (2024). NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. Journal of the National Comprehensive Cancer Network : JNCCN, 22(5), 290-298. https://doi.org/10.6004/jnccn.2024.0036

@article{53ad4bcefe1342599c19c39110bcfcf1,

title = "NCCN Guidelines{\textregistered} Insights: Melanoma: Cutaneous, Version 2.2024",

abstract = "The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.",

keywords = "Humans, Medical Oncology/standards, Melanoma/therapy, Neoplasm Staging, Skin Neoplasms/therapy",

author = "Swetter, {Susan M.} and Douglas Johnson and Albertini, {Mark R.} and Barker, {Christopher A.} and Sarah Bateni and Joel Baumgartner and Shailender Bhatia and Christopher Bichakjian and Genevieve Boland and Sunandana Chandra and Bartosz Chmielowski and Dominick DiMaio and Roxana Dronca and Fields, {Ryan C.} and Fleming, {Martin D.} and Anjela Galan and Samantha Guild and John Hyngstrom and Giorgos Karakousis and Kari Kendra and Maija Kiuru and Lange, {Julie R.} and Ryan Lanning and Theodore Logan and Daniel Olson and Olszanski, {Anthony J.} and Ott, {Patrick A.} and Ross, {Merrick I.} and Luke Rothermel and Salama, {April K.} and Rohit Sharma and Joseph Skitzki and Emily Smith and Katy Tsai and Evan Wuthrick and Yan Xing and Nicole McMillian and Sara Espinosa",

note = "Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network.",

year = "2024",

month = jul,

day = "1",

doi = "10.6004/jnccn.2024.0036",

language = "English",

volume = "22",

pages = "290--298",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "5",

}

Swetter, SM, Johnson, D, Albertini, MR, Barker, CA, Bateni, S, Baumgartner, J, Bhatia, S, Bichakjian, C, Boland, G, Chandra, S, Chmielowski, B, DiMaio, D, Dronca, R, Fields, RC, Fleming, MD, Galan, A, Guild, S, Hyngstrom, J, Karakousis, G, Kendra, K, Kiuru, M, Lange, JR, Lanning, R, Logan, T, Olson, D, Olszanski, AJ, Ott, PA, Ross, MI, Rothermel, L, Salama, AK, Sharma, R, Skitzki, J, Smith, E, Tsai, K, Wuthrick, E, Xing, Y, McMillian, N & Espinosa, S 2024, 'NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 22, no. 5, pp. 290-298. https://doi.org/10.6004/jnccn.2024.0036

TY - JOUR

T1 - NCCN Guidelines® Insights

T2 - Melanoma: Cutaneous, Version 2.2024

AU - Swetter, Susan M.

AU - Johnson, Douglas

AU - Albertini, Mark R.

AU - Barker, Christopher A.

AU - Bateni, Sarah

AU - Baumgartner, Joel

AU - Bhatia, Shailender

AU - Bichakjian, Christopher

AU - Boland, Genevieve

AU - Chandra, Sunandana

AU - Chmielowski, Bartosz

AU - DiMaio, Dominick

AU - Dronca, Roxana

AU - Fields, Ryan C.

AU - Fleming, Martin D.

AU - Galan, Anjela

AU - Guild, Samantha

AU - Hyngstrom, John

AU - Karakousis, Giorgos

AU - Kendra, Kari

AU - Kiuru, Maija

AU - Lange, Julie R.

AU - Lanning, Ryan

AU - Logan, Theodore

AU - Olson, Daniel

AU - Olszanski, Anthony J.

AU - Ott, Patrick A.

AU - Ross, Merrick I.

AU - Rothermel, Luke

AU - Salama, April K.

AU - Sharma, Rohit

AU - Skitzki, Joseph

AU - Smith, Emily

AU - Tsai, Katy

AU - Wuthrick, Evan

AU - Xing, Yan

AU - McMillian, Nicole

AU - Espinosa, Sara

PY - 2024/7/1

Y1 - 2024/7/1

N2 - The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

AB - The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

KW - Humans

KW - Medical Oncology/standards

KW - Melanoma/therapy

KW - Neoplasm Staging

KW - Skin Neoplasms/therapy

UR - http://www.scopus.com/inward/record.url?scp=85199127199&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0036

DO - 10.6004/jnccn.2024.0036

M3 - Article

C2 - 39019054

AN - SCOPUS:85199127199

SN - 1540-1405

VL - 22

SP - 290

EP - 298

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 5

ER -

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this